Advertisement
U.S. Markets close in 1 hr 34 mins

Enliven Therapeutics, Inc. (ELVN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
24.31-0.10 (-0.41%)
As of 02:24PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close24.41
Open24.30
Bid24.07 x 100
Ask24.36 x 100
Day's Range24.22 - 24.89
52 Week Range9.80 - 30.03
Volume135,302
Avg. Volume246,975
Market Cap1.188B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.89
Earnings DateNov 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est37.17
  • PR Newswire

    Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update

    Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial results for the third quarter ended September 30, 2024, and provided a business update, including highlights of pipeline progress.

  • PR Newswire

    Enliven Therapeutics to Present at the Jefferies London Healthcare Conference

    Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 9:30 a.m. GMT.